...
首页> 外文期刊>African Journal of Laboratory Medicine >Differential infectivity of gametocytes after artemisinin-based combination therapy of uncomplicated falciparum malaria
【24h】

Differential infectivity of gametocytes after artemisinin-based combination therapy of uncomplicated falciparum malaria

机译:基于青蒿素的单纯性恶性疟疾联合治疗后配子细胞的差异感染性

获取原文
           

摘要

Background: ?Most malaria-endemic countries use artemisinin-based combination therapy (ACT) as their first-line treatment. ACTs are known to be highly effective on asexual stages of the malaria parasite. Malaria transmission and the spread of resistant parasites depend on the infectivity of gametocytes. The effect of the current ACT regimens on gametocyte infectivity is unclear. Objectives: ?This study aimed to determine the infectivity of gametocytes to? Anopheles gambiae ?following ACT treatment in the field. Methods: ?During a randomised controlled trial in Bougoula-Hameau, Mali, conducted from July 2005 to July 2007, volunteers with uncomplicated malaria were randomised to receive artemether-lumefantrine, artesunate-amodiaquine, or artesunate-sulfadoxine/pyrimethamine. Volunteers were followed for 28 days, and gametocyte carriage was assessed. Direct skin feeding assays were performed on gametocyte carriers before and after ACT administration. Results: ?Following artemether-lumefantrine treatment, gametocyte carriage decreased steadily from Day 0 to Day 21 post-treatment initiation. In contrast, for the artesunate-amodiaquine and artesunate-sulfadoxine/pyrimethamine arms, gametocyte carriage increased on Day 3 and remained constant until Day 7 before decreasing afterward. Mosquito feeding assays showed that artemether-lumefantrine and artesunate-amodiaquine significantly increased gametocyte infectivity to? Anopheles gambiae sensu lato ?(s.l.) ( p ? 10 ?4 ), whereas artesunate-sulfadoxine/pyrimethamine decreased gametocyte infectivity in this setting ( p ?= 0.03). Conclusion: ?Different ACT regimens could lead to gametocyte populations with different capacity to infect the? Anopheles ?vector. Frequent assessment of the effect of antimalarials on gametocytogenesis and gametocyte infectivity may be required for the full assessment of treatment efficacy, the potential for spread of drug resistance and malaria transmission in the field.
机译:背景:?大多数疟疾流行国家使用基于青蒿素的联合治疗(ACT)作为一线治疗。已知ACT对疟疾寄生虫的无性阶段非常有效。疟疾的传播和抗性寄生虫的传播取决于配子细胞的感染性。目前的ACT方案对配子细胞感染性的影响尚不清楚。目的:这项研究旨在确定配子细胞对细菌的感染性。冈比亚按蚊-在野外进行ACT治疗。方法:在2005年7月至2007年7月于马里的Bougoula-Hameau进行的一项随机对照试验期间,将无并发症疟疾的志愿者随机分组接受青蒿琥酯-氟美特林,青蒿琥酯-阿地二醌或青蒿琥酯-磺胺多辛/乙胺嘧啶。追踪志愿者28天,并评估配子细胞的运输。在施用ACT之前和之后,在配子细胞载体上进行直接皮肤喂养测定。结果:?在进行蒿甲醚-荧光粉治疗后,从开始治疗后的第0天到第21天,配子细胞的转运稳定下降。相反,对于青蒿琥酯-氨二喹和青蒿琥酯-磺胺多辛/乙胺嘧啶臂,配子细胞的转运在第3天增加,并保持恒定直到第7天,之后才下降。蚊子喂养试验表明,蒿甲醚-荧光粉和青蒿琥酯-氨二喹显着增加了配子体对to的感染性。冈比亚按蚊(s.l.)(p <10?4),而青蒿琥酯-磺胺多辛/乙胺嘧啶在这种情况下降低了配子细胞的感染性(p = 0.03)。结论:不同的ACT方案可能导致不同的配子体感染能力。按蚊矢量。为了全面评估治疗效果,耐药性传播和疟疾传播的潜力,可能需要经常评估抗疟疾对配子发生和配子细胞感染性的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号